Inventprise

Redmond, United States

Inventprise is a biotechnology company specializing in GMP vaccine product development.

$3.5M raised

Nov 2021

Debt Financing

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Inventprise raised?

Inventprise has raised $3.5M in total funding. The most recent round was Debt Financing. The last funding was announced in November 2021.

Who are Inventprise's investors?

Inventprise's investors include Bill & Melinda Gates Foundation.

Where is Inventprise headquartered?

Inventprise is headquartered in Redmond, United States.

What does Inventprise do?

Inventprise is a biotechnology company specializing in GMP vaccine product development.

What stage is Inventprise at?

Inventprise is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 15, 2021.

MLA

"Inventprise — Funding & Investors." VCBacked, November 15, 2021, https://www.vcbacked.co/company/inventprise. Accessed July 2, 2026.

APA

VCBacked. (2021). Inventprise — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/inventprise

Wikipedia (cite web)

{{cite web |title=Inventprise — Funding & Investors |url=https://www.vcbacked.co/company/inventprise |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 15, 2021.